Depo Provera. Position paper on clinical use, effectiveness and side effects

Area of Science:

• Reproductive Health
• Pharmacology
• Contraception

Background:

• Depo Provera (medroxyprogesterone acetate, DMPA) is a highly effective injectable contraceptive.
• Its efficacy is comparable to modern copper IUDs and superior to many other reversible methods.
• DMPA offers an advantage due to its independence from intercourse and user memory, unlike daily oral contraceptives.

Purpose of the Study:

• To evaluate the effectiveness and suitability of DMPA as a first-line reversible contraceptive method.
• To highlight the importance of pre-use counseling for managing potential side effects.
• To compare DMPA with other contraceptive methods, including oral contraceptives and IUDs.

Main Methods:

• Review of DMPA's pharmacological profile and clinical effectiveness.
• Comparison of DMPA's side effect profile, particularly menstrual changes and weight gain, with other hormonal contraceptives.
• Analysis of DMPA's suitability for women with contraindications to combined oral contraceptives, such as those with focal migraines or thrombosis risk.

Main Results:

• DMPA demonstrates a very low failure rate, comparable to copper IUDs.
• Menstrual disturbance and weight gain are the primary potential disadvantages, though rarely require medical intervention and can be managed.
• DMPA has no significant impact on blood pressure or thrombosis risk, making it a safe alternative for women who cannot use combined oral contraceptives.

Conclusions:

• DMPA is a highly effective and advantageous reversible contraceptive method that should be widely available.
• Comprehensive pre-use counseling is essential to address patient concerns, manage side effects, and ensure informed choices.
• Accurate and accessible patient information is vital to combat misinformation and improve the public image of DMPA.